Fluidigm: Bill Colston
Fluidigm has appointed Bill Colston to its board of directors. Colston has served as president of iCarbonX since March. He joined the company as chief operating officer in April 2018 following its acquisition of his prior company. He is also on the board of iCarbonX. Prior to this, he was cofounder and CEO of HealthTell. He was also previously the scientific founder and CEO of QuantaLife, which originally developed the technlogy behind Bio-Rad's droplet digitial PCR products.